Physician profile
Peter N Piperis
NPI 1588690663
$4,091.67
in general payments reported to CMS, 2019-2025
22 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $465 · 2021: $755 · 2022: $415 · 2023: $423 · 2024: $1,011 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,014.56 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Synchromedii |
| Abbott Laboratories | $488.79 | 2019-2023 | Proclaim |
| Medtronic USA, INC. | $393.28 | 2019-2020 | |
| Boston Scientific Corporation | $209.32 | 2019-2025 | Patient Trial Kit |
| Spr Therapeutics, INC | $192.58 | 2022-2025 | Sprint Pns System |
| Si-Bone, INC. | $188.65 | 2019-2025 | |
| Abbvie INC. | $157.25 | 2021-2025 | |
| Vertos Medical, INC. | $69.15 | 2024 | Mild Device Kit |
| Nevro Corp. | $57.09 | 2019 | |
| Spinal Simplicity, LLC | $51.07 | 2021 | |
| Allergan, INC. | $46.66 | 2019 | |
| Stryker Corporation | $40.21 | 2025 | Mild Device Kit |
| Biodelivery Sciences International, INC. | $28.23 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $27.84 | 2022 | |
| Biotronik Nro, INC. | $22.55 | 2024 | Prospera |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $17.94 | 2023 | |
| Bioventus LLC | $17.19 | 2019 | |
| Relievant Medsystems, INC. | $15.96 | 2023 | Intracept |
| Forte Bio-Pharma LLC | $14.58 | 2025 | Prolate, Tanlor, Nalocet |
| Collegium Pharmaceutical, INC. | $13.41 | 2021 | |
| Baudax Bio INC. | $12.84 | 2022 | |
| Lilly USA, LLC | $12.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Piperis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.